What Are Allergies?

Allergies are hypersensitivity disorders in which the immune system mounts a damaging response to a substance that is harmless to most people. The triggering substance, called an allergen, is typically a protein from pollen, house dust mite, animal dander, mold, insect venom, food, or a drug. Allergic disease is defined by the immune mechanism rather than by the organ affected, which is why conditions as different as seasonal rhinitis, eczema, asthma, and anaphylaxis after a peanut exposure belong to one category. Prevalence has risen across industrialized countries over several decades, and the reasons remain contested.

The subject sits between immunology and clinical medicine, and it has a substantial engineering component because diagnosis, monitoring, and treatment all depend on instrumentation: immunoassay analyzers, flow cytometers, protein microarrays, autoinjectors, and environmental samplers.

Immunological Mechanism

The classic allergic reaction is a type I, immediate hypersensitivity mediated by immunoglobulin E. On first exposure the immune system produces allergen-specific IgE, which binds the high-affinity FcεRI receptor on mast cells and basophils, a silent process called sensitization. On re-exposure the allergen cross-links adjacent IgE molecules on the cell surface and triggers degranulation within minutes, releasing histamine, tryptase, and newly synthesized leukotrienes and prostaglandins. Those mediators produce vasodilation, increased vascular permeability, smooth muscle contraction, and mucus secretion, which accounts for the immediate symptom pattern. A late phase response follows hours later as eosinophils and T helper cells are recruited to the tissue. Not all allergic disease follows this route: contact dermatitis to nickel or poison ivy is a delayed, T cell mediated reaction, and several food-related conditions are non-IgE mediated. Sensitization alone does not establish disease, since many people carry detectable specific IgE without clinical reactions, a distinction the NIAID-sponsored expert panel guidelines on food allergy treat as central to correct diagnosis.

Clinical Presentations

Allergic rhinitis and conjunctivitis affect the upper airway and eye and are the most common presentations. Allergic asthma involves lower airway inflammation, bronchial hyperresponsiveness, and reversible obstruction measurable by spirometry. Atopic dermatitis presents as chronic barrier-disrupted skin inflammation and often precedes airway disease in the pattern clinicians call the atopic march. Food allergy, insect sting allergy, and drug allergy can produce anaphylaxis, a rapid multisystem reaction involving airway compromise, circulatory collapse, or both, which is a medical emergency treated with intramuscular epinephrine.

Diagnostic Testing and Instrumentation

Diagnosis begins with a clinical history and is supported by two sensitization tests. The skin prick test introduces a standardized allergen extract into the epidermis and measures the resulting wheal against positive and negative controls, and studies of the sensitivity and specificity of standardized extracts in skin prick testing show performance depends heavily on extract quality and reader technique. Serum specific IgE is quantified by fluoroenzyme or chemiluminescent immunoassay on automated analyzers. Component-resolved diagnostics measure IgE against individual purified allergen proteins rather than whole extracts, often on a microarray, which separates clinically risky sensitizations from cross-reactive ones; current practice is reviewed in work on how to diagnose IgE-mediated food allergy. The basophil activation test uses flow cytometry to measure surface marker upregulation after in vitro allergen challenge. Lateral flow and other point-of-care formats have been evaluated against laboratory methods, as in an assessment of a rapid test system for allergic sensitization to grass pollen. The supervised oral food challenge remains the reference standard when testing is ambiguous.

Management

Care combines allergen avoidance, pharmacotherapy with antihistamines, intranasal corticosteroids, and leukotriene modifiers, and rescue epinephrine for anaphylaxis. Allergen immunotherapy, delivered subcutaneously, sublingually, or as oral food immunotherapy, gradually raises the reaction threshold and is the only treatment that modifies the underlying sensitization. Monoclonal antibodies against IgE and against type 2 cytokines extend options for severe disease.

Applications

Allergy research and care intersect with a range of technical fields, including:

• Clinical immunoassay analyzers and protein microarray platforms
• Biosensors and point-of-care diagnostic devices
• Pollen and airborne particle monitoring networks
• Food processing, allergen detection, and labeling compliance
• Autoinjector and inhaler drug delivery engineering
• Indoor air filtration and building ventilation design